Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-31

Clinical Trial Update: Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV [Phase 4]

View source ↗

Summary

Phase 4 study investigated the effect of dosing HSV-2 suppressive therapy on genital herpes and HIV infection; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: Genital Herpes, HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2012-07-31